Wall Street brokerages expect Miragen Therapeutics, Inc. (NASDAQ:MGEN) to post sales of $230,000.00 for the current fiscal quarter, Zacks reports. Two analysts have made estimates for Miragen Therapeutics’ earnings. The lowest sales estimate is $50,000.00 and the highest is $400,000.00. Miragen Therapeutics reported sales of $880,000.00 during the same quarter last year, which indicates a […]